UK biotech Phynova makes a business out of developing traditional medicines, but when it comes to raising money it is pioneering a new, low-cost route to American investors.

There was an unprecedented number of cybersquatting cases in 2007, according to the latest statistics from the World Intellectual Property Organisation.